Cargando…
A nanoparticle-based COVID-19 vaccine candidate elicits broad neutralizing antibodies and protects against SARS-CoV-2 infection
A vaccine candidate to SARS-CoV-2 was constructed by coupling the viral receptor binding domain (RBD) to the surface of the papaya mosaic virus (PapMV) nanoparticle (nano) to generate the RBD-PapMV vaccine. Immunization of mice with the coupled RBD-PapMV vaccine enhanced the antibody titers and the...
Autores principales: | Olivera-Ugarte, Santa-Mariela, Bolduc, Marilène, Laliberté-Gagné, Marie-Ève, Blanchette, Léa-Jeanne, Garneau, Caroline, Fillion, Maude, Savard, Pierre, Dubuc, Isabelle, Flamand, Louis, Farnòs, Omar, Xu, Xingge, Kamen, Amine, Gilbert, Mégan, Rabezanahary, Henintsoa, Scarrone, Martina, Couture, Christian, Baz, Mariana, Leclerc, Denis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9287509/ https://www.ncbi.nlm.nih.gov/pubmed/35850421 http://dx.doi.org/10.1016/j.nano.2022.102584 |
Ejemplares similares
-
Modulation of Antigen Display on PapMV Nanoparticles Influences Its Immunogenicity
por: Laliberté-Gagné, Marie-Eve, et al.
Publicado: (2021) -
Increased Immunogenicity of Full-Length Protein Antigens through Sortase-Mediated Coupling on the PapMV Vaccine Platform
por: Laliberté-Gagné, Marie-Ève, et al.
Publicado: (2019) -
PapMV nanoparticles improve mucosal immune responses to the trivalent inactivated flu vaccine
por: Rioux, Gervais, et al.
Publicado: (2014) -
Influence of PapMV nanoparticles on the kinetics of the antibody response to flu vaccine
por: Rioux, Gervais, et al.
Publicado: (2016) -
Improvement of the Trivalent Inactivated Flu Vaccine Using PapMV Nanoparticles
por: Savard, Christian, et al.
Publicado: (2011)